ArticlesBioPharma August 25, 2023 Balancing AAVs Versus LLVs Knowledge of adeno-associated variant's infection pathway is based on only a few serotypes. admin-element
ArticlesDownstream August 25, 2023 Get more from UNICORN™ software with plug-in extensions Access extensions for UNICORN software from the new Cytiva Marketplace, including a free... admin-element
Articles August 10, 2023 mRNA Global Alliance Tests the Waters at BIO World leaders have set ambitious goals to respond more swiftly to the next pandemic, including... admin-element
ArticlesDownstream August 10, 2023 Digitalized PD: Speeding up downstream process development Mechanistic models enable the simulation of chromatography processes based on fundamental... admin-element
ArticlesUpstream July 28, 2023 Xcellerex™ X-platform bioreactor live virtual demo We designed Xcellerex™ X-platform bioreactors to meet your process needs today and in the future. admin-element
ArticlesBioPharma July 28, 2023 Weighing the Benefits of Single-Use Consumables While the debate between stainless steel and single-use systems (SUS) will continue to rage for... admin-element
ArticlesBioPharma July 13, 2023 Pulling Out All the Stops in mAb Manufacturing While the biopharma industry is pushing the barriers with antibody development, it must also contend… admin-element
Articles July 13, 2023 Host cell protein quantitation using ELISA Host cell proteins (HCPs) produced by cells during biologic manufacturing must be removed from the… admin-element
Articles July 13, 2023 Get a strong start in oligonucleotide manufacturing Oligonucleotide therapeutics hold incredible promise. How can you harness their full potential? admin-element
ArticlesUpstream June 29, 2023 Future-proof your AAV process with a complete producer cell line – just induce and grow Stable producer cell lines helped to make mAb therapies the powerhouses they are today. admin-element